Interest Expense in USD of DEXCOM INC from Q2 2010 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of the cost of borrowed funds accounted for as interest expense.
Summary
DEXCOM INC quarterly/annual Interest Expense history and change rate from Q2 2010 to Q1 2024.
  • DEXCOM INC Interest Expense for the quarter ending 31 Mar 2024 was $4.6M, unchanged year-over-year.
  • DEXCOM INC Interest Expense for the twelve months ending 31 Mar 2024 was $20.3M, a 9.14% increase year-over-year.
  • DEXCOM INC annual Interest Expense for 2023 was $20.3M, a 9.14% increase from 2022.
  • DEXCOM INC annual Interest Expense for 2022 was $18.6M, a 1.06% decline from 2021.
  • DEXCOM INC annual Interest Expense for 2021 was $18.8M, a 6.22% increase from 2020.
Interest Expense, Trailing 12 Months (USD)
Interest Expense, Quarterly (USD)
Interest Expense, YoY Quarterly Change (%)
Interest Expense, Annual (USD)
Interest Expense, YoY Annual Change (%)

DEXCOM INC Quarterly Interest Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $20.3M $4.6M $0 0% 01 Jan 2024 31 Mar 2024 10-Q 25 Apr 2024
Q4 2023 $20.3M $4.9M +$200K +4.26% 01 Oct 2023 31 Dec 2023 10-K 08 Feb 2024
Q3 2023 $20.1M $4.9M +$300K +6.52% 01 Jul 2023 30 Sep 2023 10-Q 26 Oct 2023
Q2 2023 $19.8M $5.9M +$1.2M +25.5% 01 Apr 2023 30 Jun 2023 10-Q 27 Jul 2023
Q1 2023 $18.6M $4.6M $0 0% 01 Jan 2023 31 Mar 2023 10-Q 25 Apr 2024
Q4 2022 $18.6M $4.7M $0 0% 01 Oct 2022 31 Dec 2022 10-K 08 Feb 2024
Q3 2022 $18.6M $4.6M $0 0% 01 Jul 2022 30 Sep 2022 10-Q 26 Oct 2023
Q2 2022 $18.6M $4.7M -$100K -2.08% 01 Apr 2022 30 Jun 2022 10-Q 27 Jul 2023
Q1 2022 $18.7M $4.6M -$100K -2.13% 01 Jan 2022 31 Mar 2022 10-Q 27 Apr 2023
Q4 2021 $18.8M $4.7M +$47.1M 01 Oct 2021 31 Dec 2021 10-K 08 Feb 2024
Q3 2021 -$28.3M $4.6M -$19.8M -81.1% 01 Jul 2021 30 Sep 2021 10-Q 27 Oct 2022
Q2 2021 -$8.5M $4.8M -$15.5M -76.4% 01 Apr 2021 30 Jun 2021 10-Q 28 Jul 2022
Q1 2021 $7M $4.7M -$10.7M -69.5% 01 Jan 2021 31 Mar 2021 10-Q 28 Apr 2022
Q4 2020 $17.7M -$42.4M -$57.7M -377% 01 Oct 2020 31 Dec 2020 10-K 09 Feb 2023
Q3 2020 $75.4M $24.4M +$9.3M +61.6% 01 Jul 2020 30 Sep 2020 10-Q 28 Oct 2021
Q2 2020 $66.1M $20.3M +$5.3M +35.3% 01 Apr 2020 30 Jun 2020 10-Q 29 Jul 2021
Q1 2020 $60.8M $15.4M +$500K +3.36% 01 Jan 2020 31 Mar 2020 10-Q 29 Apr 2021
Q4 2019 $60.3M $15.3M +$7.1M +86.6% 01 Oct 2019 31 Dec 2019 10-K 14 Feb 2022
Q3 2019 $53.2M $15.1M +$10.2M +208% 01 Jul 2019 30 Sep 2019 10-Q 27 Oct 2020
Q2 2019 $43M $15M +$10.2M +213% 01 Apr 2019 30 Jun 2019 10-Q 28 Jul 2020
Q1 2019 $32.8M $14.9M +$10.1M +210% 01 Jan 2019 31 Mar 2019 10-Q 28 Apr 2020
Q4 2018 $22.7M $8.2M +$3.5M +74.5% 01 Oct 2018 31 Dec 2018 10-K 11 Feb 2021
Q3 2018 $19.2M $4.9M +$400K +8.89% 01 Jul 2018 30 Sep 2018 10-Q 06 Nov 2019
Q2 2018 $18.8M $4.8M +$1.7M +54.8% 01 Apr 2018 30 Jun 2018 10-Q 31 Jul 2019
Q1 2018 $17.1M $4.8M +$4.3M +860% 01 Jan 2018 31 Mar 2018 10-Q 01 May 2019
Q4 2017 $12.8M $4.7M +$4.4M +1467% 01 Oct 2017 31 Dec 2017 10-K 13 Feb 2020
Q3 2017 $8.4M $4.5M +$4.3M +2150% 01 Jul 2017 30 Sep 2017 10-Q 06 Nov 2018
Q2 2017 $4.1M $3.1M +$3M +3000% 01 Apr 2017 30 Jun 2017 10-Q 01 Aug 2018
Q1 2017 $1.1M $500K +$400K +400% 01 Jan 2017 31 Mar 2017 10-Q 02 May 2018
Q4 2016 $700K $300K +$300K 01 Oct 2016 31 Dec 2016 10-K 21 Feb 2019
Q3 2016 $400K $200K +$100K +100% 01 Jul 2016 30 Sep 2016 10-Q 01 Nov 2017
Q2 2016 $300K $100K $0 0% 01 Apr 2016 30 Jun 2016 10-Q 01 Aug 2017
Q1 2016 $300K $100K -$100K -50% 01 Jan 2016 31 Mar 2016 10-Q 02 May 2017
Q4 2015 $400K $0 -$200K -100% 01 Oct 2015 31 Dec 2015 10-K 27 Feb 2018
Q3 2015 $600K $100K -$100K -50% 01 Jul 2015 30 Sep 2015 10-Q 01 Nov 2016
Q2 2015 $700K $100K -$100K -50% 01 Apr 2015 30 Jun 2015 10-Q 02 Aug 2016
Q1 2015 $800K $200K $0 0% 01 Jan 2015 31 Mar 2015 10-Q 27 Apr 2016
Q4 2014 $800K $200K -$100K -33.3% 01 Oct 2014 31 Dec 2014 10-K 28 Feb 2017
Q3 2014 $900K $200K $0 0% 01 Jul 2014 30 Sep 2014 10-Q 04 Nov 2015
Q2 2014 $900K $200K $0 0% 01 Apr 2014 30 Jun 2014 10-Q 05 Aug 2015
Q1 2014 $900K $200K $0 0% 01 Jan 2014 31 Mar 2014 10-Q 29 Apr 2015
Q4 2013 $900K $300K +$100K +50% 01 Oct 2013 31 Dec 2013 10-K 23 Feb 2016
Q3 2013 $800K $200K +$200K 01 Jul 2013 30 Sep 2013 10-Q 06 Nov 2014
Q2 2013 $600K $200K +$200K 01 Apr 2013 30 Jun 2013 10-Q 06 Aug 2014
Q1 2013 $400K $200K +$200K 01 Jan 2013 31 Mar 2013 10-Q 01 May 2014
Q4 2012 $200K $200K +$3.21M 01 Oct 2012 31 Dec 2012 10-K 25 Feb 2015
Q3 2012 -$3.01M $0 -$1K 01 Jul 2012 30 Sep 2012 10-Q 06 Nov 2013
Q2 2012 -$3.01M $0 -$3M -100% 01 Apr 2012 30 Jun 2012 10-Q 07 Aug 2013
Q1 2012 -$6K $0 -$6K 01 Jan 2012 31 Mar 2012 10-Q 01 May 2013
Q4 2011 $0 -$3.01M 01 Oct 2011 31 Dec 2011 10-K 20 Feb 2014
Q3 2011 $1K* -$43K 01 Jul 2011 30 Sep 2011 10-Q 01 Nov 2012
Q2 2011 $3M +$2.8M +1423% 01 Apr 2011 30 Jun 2011 10-Q 06 Aug 2012
Q1 2011 $6K* 01 Jan 2011 31 Mar 2011 10-Q 02 May 2012
Q3 2010 $44K 01 Jul 2010 30 Sep 2010 10-Q 02 Nov 2011
Q2 2010 $197K 01 Apr 2010 30 Jun 2010 10-Q 03 Aug 2011

DEXCOM INC Annual Interest Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $20.3M +$1.7M +9.14% 01 Jan 2023 31 Dec 2023 10-K 08 Feb 2024
2022 $18.6M -$200K -1.06% 01 Jan 2022 31 Dec 2022 10-K 08 Feb 2024
2021 $18.8M +$1.1M +6.22% 01 Jan 2021 31 Dec 2021 10-K 08 Feb 2024
2020 $17.7M -$42.6M -70.6% 01 Jan 2020 31 Dec 2020 10-K 09 Feb 2023
2019 $60.3M +$37.6M +166% 01 Jan 2019 31 Dec 2019 10-K 14 Feb 2022
2018 $22.7M +$9.9M +77.3% 01 Jan 2018 31 Dec 2018 10-K 11 Feb 2021
2017 $12.8M +$12.1M +1729% 01 Jan 2017 31 Dec 2017 10-K 13 Feb 2020
2016 $700K +$300K +75% 01 Jan 2016 31 Dec 2016 10-K 21 Feb 2019
2015 $400K -$400K -50% 01 Jan 2015 31 Dec 2015 10-K 27 Feb 2018
2014 $800K -$100K -11.1% 01 Jan 2014 31 Dec 2014 10-K 28 Feb 2017
2013 $900K +$700K +350% 01 Jan 2013 31 Dec 2013 10-K 23 Feb 2016
2012 $200K +$200K 01 Jan 2012 31 Dec 2012 10-K 25 Feb 2015
2011 $0 -$1.5M -100% 01 Jan 2011 31 Dec 2011 10-K 20 Feb 2014
2010 $1.5M 01 Jan 2010 31 Dec 2010 10-K 21 Feb 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.